$RXMD News: Progressive Care Announces New Partnership With

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
152
$RXMD News: Progressive Care Announces New Partnership With MyApps, Discontinues Plans to Acquire the Company

MIAMI, FL, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that the Letter of Intent (the “LOI”) entered into on September 1, 2020, for the Company to acquire substantially all of MyApps Corp. (“MyApps”) has been terminated by the companies.

Progressive Care and MyApps will continue to work together amicably as partners, and the companies’ near-term priority will be to integrate CallingDr™, the popular telemedicine and telehealth platform developed by MyApps, into Progressive Care’s PharmcoRx digital platform and work together to enhance Progressive Care’s ClearMetrX data analytics and data management services.

“As the companies were working diligently towards an acquisition, it became increasingly clear that the parties would be better suited to be partners than to be a single organization,” said Progressive Care Chief Executive Officer Alan Jay Weisberg. “We’re extremely excited to continue our partnership to make the CallingDr™ software platform an integral part of our digital offerings.”

“Our enthusiasm about working together with Progressive Care remains unchanged,” said MyApps Founder and CEO, Adnan Malik. “After broad and intensive analysis, we collectively have concluded that we will be able to achieve more as separate entities working as allies, and we have already identified areas in which we believe we can add tangible value to Progressive Care’s offerings.”

“MyApps’ extensive and relevant experience with healthcare software development will be highly additive to our goals with ClearMetrX,” said Mr. Weisberg. “We welcome their expertise, and we remain committed as ever to exploring all meaningful ways to benefit our shareholders, employees and customers.”

For more information about Progressive Care, please visit the company’s website:

https://www.ProgressiveCareUS.com

‍

Connect and stay in touch with us on social media:

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS

‍

PharmCo Rx

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to longterm care facilities and health practice risk management.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited statements regarding the planned partnership between the Company and MyApps, including potential integration of CallingDr™ into the PharmcoRx digital platform and working together to enhance ClearMetrX data analytics and data management services. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forwardlooking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company’s actual results, performance, prospects and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:

Carlos Rangel

carlosr@pharmcorx.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of $100 Investment in TD Synnex - A 20-Year Review

Updated Category News Views 201

Understanding the Value of Long-Term Investments Investing can often feel daunting, but the story of TD Synnex (NYSE: SNX) illustrates the powerful potential of long-term commitment. Over the last two decades, the company's stock has outperformed the broader market, delivering compelling returns to its investors. The Journey of TD Synnex Over the Past 20 Years During this...

Continue Reading
Growth of Nuclear Medicine Software Market Expected to Surge

Updated Category News Views 101

Emerging Trends in the Nuclear Medicine Software Market The nuclear medicine software market is poised for significant growth, projected to reach approximately US$1,491.55 million by 2030. This represents a compound annual growth rate (CAGR) of 9.0% from its current valuation. As healthcare continues to evolve, the demand for precise and early diagnostics is paramount,...

Continue Reading
Quanterix Corporation Faces Investigation Amid Investor Concerns

Updated Category News Views 400

Quanterix Corporation Faces Scrutiny from Rosic Law Firm In a recent development, Quanterix Corporation (NASDAQ: QTRX) has come under investigation by the Rosen Law Firm. This esteemed global investor rights law firm is exploring potential securities claims on behalf of the company's shareholders. The investigation arises from allegations of misleading business...

Continue Reading
Navigating Market Dynamics: Strategies for Today's Investors

Updated Category News Views 139

Understanding Market Strategies To excel in today's stock market, it's essential to have a keen understanding of various investment strategies. The current landscape suggests that savvy investors can find profitable opportunities even amid volatility. Taking Advantage of Hedges In light of recent sell-offs, a prudent strategy involves taking partial profits on hedges....

Continue Reading
Celebrate the Magic of Middle-earth: A Unique Reunion Tour

Updated Category News Views 246

FAN EXPO Celebrates 25 Years of The Lord of the Rings FAN EXPO HQ is thrilled to announce a special celebration marking the 25th anniversary of the iconic film, The Lord of the Rings. This memorable event, titled An Evening with the Hobbits: In Celebration of 25 Years, will take place in 11 cities across North America, starting in January. Key cast members Elijah Wood,...

Continue Reading